Skip to main content
eScholarship
Open Access Publications from the University of California

UCLA

UCLA Previously Published Works bannerUCLA

Exome Sequencing for Prenatal Diagnosis in Nonimmune Hydrops Fetalis.

  • Author(s): Sparks, Teresa N
  • Lianoglou, Billie R
  • Adami, Rebecca R
  • Pluym, Ilina D
  • Holliman, Kerry
  • Duffy, Jennifer
  • Downum, Sarah L
  • Patel, Sachi
  • Faubel, Amanda
  • Boe, Nina M
  • Field, Nancy T
  • Murphy, Aisling
  • Laurent, Louise C
  • Jolley, Jennifer
  • Uy, Cherry
  • Slavotinek, Anne M
  • Devine, Patrick
  • Hodoglugil, Ugur
  • Van Ziffle, Jessica
  • Sanders, Stephan J
  • MacKenzie, Tippi C
  • Norton, Mary E
  • University of California Fetal–Maternal Consortium
  • University of California, San Francisco Center for Maternal–Fetal Precision Medicine
  • et al.
Abstract

Background

The cause of most fetal anomalies is not determined prenatally. Exome sequencing has transformed genetic diagnosis after birth, but its usefulness for prenatal diagnosis is still emerging. Nonimmune hydrops fetalis (NIHF), a fetal abnormality that is often lethal, has numerous genetic causes; the extent to which exome sequencing can aid in its diagnosis is unclear.

Methods

We evaluated a series of 127 consecutive unexplained cases of NIHF that were defined by the presence of fetal ascites, pleural or pericardial effusions, skin edema, cystic hygroma, increased nuchal translucency, or a combination of these conditions. The primary outcome was the diagnostic yield of exome sequencing for detecting genetic variants that were classified as either pathogenic or likely pathogenic according to the criteria of the American College of Medical Genetics and Genomics. Secondary outcomes were the percentage of cases associated with specific genetic disorders and the proportion of variants that were inherited.

Results

In 37 of the 127 cases (29%), we identified diagnostic genetic variants, including those for disorders affecting the RAS-MAPK cell-signaling pathway (known as RASopathies) (30% of the genetic diagnoses); inborn errors of metabolism and musculoskeletal disorders (11% each); lymphatic, neurodevelopmental, cardiovascular, and hematologic disorders (8% each); and others. Prognoses ranged from a relatively mild outcome to death during the perinatal period. Overall, 68% of the cases (25 of 37) with diagnostic variants were autosomal dominant (of which 12% were inherited and 88% were de novo), 27% (10 of 37) were autosomal recessive (of which 95% were inherited and 5% were de novo), 1 was inherited X-linked recessive, and 1 was of uncertain inheritance. We identified potentially diagnostic variants in an additional 12 cases.

Conclusions

In this large case series of 127 fetuses with unexplained NIHF, we identified a diagnostic genetic variant in approximately one third of the cases. (Funded by the UCSF Center for Maternal-Fetal Precision Medicine and others; ClinicalTrials.gov number, NCT03412760.).

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View